May 15, 25 2025
Expanding the CMO Role: The Value of Difference
Expanding the CMO Role: The Value of Difference
Drawing on their respective backgrounds in clinical development and medical affairs, Dr. Brownstein and Dr. Louis explore how different career experiences shape decision-making, stakeholder engagement, and development strategies within the CMO role.
Being a CMO with medical affairs expertise often brings a broader focus on patient access, payer engagement, and real-world adoption, while those from clinical development backgrounds typically lead with regulatory strategy and trial execution. Dr. Brownstein and Dr. Louis explore how both profiles shape the CMO role, and why aligning clinical programs with real-world use is becoming increasingly important. The medical affairs perspective remains less common in biotech leadership today but offers growing strategic value across early and late-stage development.
They also discuss how some biotech companies are shifting focus from oncology to immunology and metabolic diseases, partly in response to changing investment trends. This shift brings new challenges for leadership teams, including recalibrating risk-benefit expectations, regulatory standards, and long-term access planning.
The episode closes with a discussion on the importance of deliberate career development and mentorship, particularly in supporting diverse leadership pipelines. Dr. Louis shares practical advice on planning career moves over a five-year horizon, gaining cross-functional experience, and driving leadership advancement with strategic intent.
Are you leading a biotech and would like to share your experience with our podcast audience? We'd love to hear from you! letstalk@ssistrategy.com
More Episodes Like This
From Academia to Biotech: Making the Transition into Biotech Leadership
When the Science Becomes a Company
Flexible Leadership in Biotech: Building Teams Around Program Needs
Designing Studies that Work in Complex Settings
Rethinking Trial Design for Rare Diseases
Driving Global Patient Access: Managed Access as a Strategic Lever
LET’S TALK
You don't have to go it alone! Our experienced team has been there before, and we're ready to guide you through the unknown. Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.
Building Better Biotechs.